AlignRx Consulting vs Venel: Revenue, Funding & Team Size Compared
AlignRx Consulting generates $5.2M in revenue; Venel generates $5.3M. Venel and AlignRx Consulting are close to the same size by revenue. The table below compares AlignRx Consulting and Venel on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  AlignRx ConsultingThis company |  Venel |
|---|---|---|
| Revenue | $5.2M | $5.3M |
| Team size | 15 | 48 |
| Founded | 2018 | Not disclosed |
| HQ | Williamsville, United States | Omaha, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
AlignRx Consulting at a glance
AlignRx Consulting generates $5.2M in revenue with 15 employees, headquartered in Williamsville, United States.
- Revenue
- $5.2M
- Team size
- 15
- Founded
- 2018
Partnering with health care benefit brokers, employer groups and health plans to offer pharmacy benefit consulting solutions
Venel at a glance
Venel generates $5.3M in revenue with 48 employees, headquartered in Omaha, United States.
- Revenue
- $5.3M
- Team size
- 48
We provide the patient-growth strategies that win. Exclusively for over 35 years, Venel has pioneered patient-growth strategies for orthopaedic practices nationwide, guiding thousands of orthopaedic surgeons through intricate discussions…
Other AlignRx Consulting alternatives
AlignRx Consulting competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
AlignRx Consulting vs Venel: frequently asked questions
Is AlignRx Consulting or Venel bigger?
Venel is the bigger company by revenue, at $5.3M against $5.2M for AlignRx Consulting.
How much revenue does AlignRx Consulting make?
AlignRx Consulting generates $5.2M in annual revenue with a team of 15.
How much revenue does Venel make?
Venel generates $5.3M in annual revenue with a team of 48.